HIV

1 which of the following statements are true about post-exposure prophylaxis or PEP in HIV treatment
I must be started within 72 hours of coming into contact with the virus.
II PEP is a month-long treatment
III start within 24 hrs of exposure to virus

2 which of the of cell count is done in HIV patients
I leucocyte count
II CD4+ve lymphocyte cells
III monocyte count

3 which of the following are true about HIV treatment
I monitoring the amount of virus in your blood is necessary
II Treatment is usually begin when CD4 cell count falls towards 350 or below
III monitoring is started only after the treatment started

4 in patients with which of the following conditions treatment is started when CD4 count falls below 500.
I hepatitis C
II hepatitis B
III cancer

5 The risk of a person living with HIV, who is taking effective antiretroviral therapy (ART), passing HIV on to sexual partners through vaginal intercourse is very low, under the following conditions
I no other sexually transmitted infections in either partner.
II viral load level below 50 copies/ml (an undetectable viral load) for more than six months
III viral load level below 50 copies/ml (an undetectable viral load) for a week

6 people should do an HIV test if they have had
I have been diagnosed with tuberculosis, hepatitis,
II unprotected sex
III injected drugs

7 the most advanced stage of HIV is
I AIDS
II tuberculosis
III cancer

8 if HIV test gives a negative results means
I free of virus
II tested too early after infection.
III tested very late

9 what is mechanism of action of nucleotide reverse transcriptase inhibitors (NRTIs)
I interrupt the HIV replication cycle
II inhibition of HIV reverse transcriptase
III termination of the DNA chain.

10 what are the risk of abacavir treatment
I hypersensitivity reactions
II fatal lactic acidosis
III severe hepatomegaly with steatosis